https://www.selleckchem.com/JAK.html
To examine nationwide variations in inpatient use of drug-coated balloons (DCBs) for treating femoropopliteal segment occlusive disease and whether DCBs are associated with reduced early out-of-hospital health care utilization. The study included 24,022 patients who survived hospitalization for femoropopliteal revascularization using DCB angioplasty (n=785 or uncoated balloon angioplasty (n=16,172) in the 2016-2017 Nationwide Readmissions Database. Differences in patient, hospitalization, and institutional characteristics were compared between tre
إعجاب
علق
شارك
